Global Repurposed Drugs Market Research Report 2025(Status and Outlook)

March 2025 | 209 pages | ID: G87CC50FF57AEN
Bosson Research

Abstracts

Report Overview

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

This report provides a deep insight into the global Repurposed Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Repurposed Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Repurposed Drugs market in any manner.

Global Repurposed Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Teva

Novartis

Mylan

Johnson & Johnson

Pfizer

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Market Segmentation (by Type)

Generic Drugs

Clinical Trial Failed Drugs

Market Segmentation (by Application)

Cardiovascular Diseases

Mental Illness

Cancer

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Repurposed Drugs Market
• Overview of the regional outlook of the Repurposed Drugs Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Repurposed Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Repurposed Drugs
1.2 Key Market Segments
1.2.1 Repurposed Drugs Segment by Type
1.2.2 Repurposed Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Repurposed Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Repurposed Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Repurposed Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Repurposed Drugs Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Repurposed Drugs Product Life Cycle
3.3 Global Repurposed Drugs Sales by Manufacturers (2020-2025)
3.4 Global Repurposed Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Repurposed Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Repurposed Drugs Manufacturing Sites, Area Served, Product Type
3.8 Repurposed Drugs Market Competitive Situation and Trends
3.8.1 Repurposed Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Repurposed Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Repurposed Drugs Industry Chain Analysis
4.1 Repurposed Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Repurposed Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Repurposed Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Repurposed Drugs Market
5.7 ESG Ratings of Leading Companies
6 Global Repurposed Drugs Market by Region
6.1 Global Repurposed Drugs Market Size by Region
6.1.1 Global Repurposed Drugs Market Size by Region
6.1.2 Global Repurposed Drugs Market Size Market Share by Region
6.2 Global Repurposed Drugs Sales by Region
6.2.1 Global Repurposed Drugs Sales by Region
6.2.2 Global Repurposed Drugs Sales Market Share by Region
7 North America Market Overview
7.1 North America Repurposed Drugs Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Repurposed Drugs Market Size by Type
7.3 North America Repurposed Drugs Market Size by Application
8 Europe Market Overview
8.1 Europe Repurposed Drugs Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Repurposed Drugs Market Size by Type
8.3 Europe Repurposed Drugs Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Repurposed Drugs Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Repurposed Drugs Market Size by Type
9.3 Asia-Pacific Repurposed Drugs Market Size by Application
10 South America Market Overview
10.1 South America Repurposed Drugs Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Repurposed Drugs Market Size by Type
10.3 South America Repurposed Drugs Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Repurposed Drugs Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Repurposed Drugs Market Size by Type
11.3 Middle East and Africa Repurposed Drugs Market Size by Application
12 Repurposed Drugs Market Production by Region
12.1 Global Production of Repurposed Drugs by Region(2020-2025)
12.2 Global Repurposed Drugs Revenue Market Share by Region (2020-2025)
12.3 Global Repurposed Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Repurposed Drugs Production
12.4.1 North America Repurposed Drugs Production Growth Rate (2020-2025)
12.4.2 North America Repurposed Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Repurposed Drugs Production
12.5.1 Europe Repurposed Drugs Production Growth Rate (2020-2025)
12.5.2 Europe Repurposed Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Repurposed Drugs Production (2020-2025)
12.6.1 Japan Repurposed Drugs Production Growth Rate (2020-2025)
12.6.2 Japan Repurposed Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Repurposed Drugs Production (2020-2025)
12.7.1 China Repurposed Drugs Production Growth Rate (2020-2025)
12.7.2 China Repurposed Drugs Production, Revenue, Price and Gross Margin (2020-2025)
13 Repurposed Drugs Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Repurposed Drugs Sales Market Share by Type (2020-2033)
13.3 Global Repurposed Drugs Market Size Market Share by Type (2020-2033)
13.4 Global Repurposed Drugs Price by Type (2020-2033)
14 Repurposed Drugs Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Repurposed Drugs Market Sales by Application (2020-2033)
14.3 Global Repurposed Drugs Market Size (M USD) by Application (2020-2033)
14.4 Global Repurposed Drugs Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Teva
15.1.1 Teva Basic Information
15.1.2 Teva Repurposed Drugs Product Overview
15.1.3 Teva Repurposed Drugs Product Market Performance
15.1.4 Teva Business Overview
15.1.5 Teva SWOT Analysis
15.1.6 Teva Recent Developments
15.2 Novartis
15.2.1 Novartis Basic Information
15.2.2 Novartis Repurposed Drugs Product Overview
15.2.3 Novartis Repurposed Drugs Product Market Performance
15.2.4 Novartis Business Overview
15.2.5 Novartis SWOT Analysis
15.2.6 Novartis Recent Developments
15.3 Mylan
15.3.1 Mylan Basic Information
15.3.2 Mylan Repurposed Drugs Product Overview
15.3.3 Mylan Repurposed Drugs Product Market Performance
15.3.4 Mylan Business Overview
15.3.5 Mylan SWOT Analysis
15.3.6 Mylan Recent Developments
15.4 Johnson and Johnson
15.4.1 Johnson and Johnson Basic Information
15.4.2 Johnson and Johnson Repurposed Drugs Product Overview
15.4.3 Johnson and Johnson Repurposed Drugs Product Market Performance
15.4.4 Johnson and Johnson Business Overview
15.4.5 Johnson and Johnson Recent Developments
15.5 Pfizer
15.5.1 Pfizer Basic Information
15.5.2 Pfizer Repurposed Drugs Product Overview
15.5.3 Pfizer Repurposed Drugs Product Market Performance
15.5.4 Pfizer Business Overview
15.5.5 Pfizer Recent Developments
15.6 Bausch Health
15.6.1 Bausch Health Basic Information
15.6.2 Bausch Health Repurposed Drugs Product Overview
15.6.3 Bausch Health Repurposed Drugs Product Market Performance
15.6.4 Bausch Health Business Overview
15.6.5 Bausch Health Recent Developments
15.7 GSK
15.7.1 GSK Basic Information
15.7.2 GSK Repurposed Drugs Product Overview
15.7.3 GSK Repurposed Drugs Product Market Performance
15.7.4 GSK Business Overview
15.7.5 GSK Recent Developments
15.8 ChemRar Group
15.8.1 ChemRar Group Basic Information
15.8.2 ChemRar Group Repurposed Drugs Product Overview
15.8.3 ChemRar Group Repurposed Drugs Product Market Performance
15.8.4 ChemRar Group Business Overview
15.8.5 ChemRar Group Recent Developments
15.9 Glenmark
15.9.1 Glenmark Basic Information
15.9.2 Glenmark Repurposed Drugs Product Overview
15.9.3 Glenmark Repurposed Drugs Product Market Performance
15.9.4 Glenmark Business Overview
15.9.5 Glenmark Recent Developments
15.10 Fujifilm
15.10.1 Fujifilm Basic Information
15.10.2 Fujifilm Repurposed Drugs Product Overview
15.10.3 Fujifilm Repurposed Drugs Product Market Performance
15.10.4 Fujifilm Business Overview
15.10.5 Fujifilm Recent Developments
15.11 Dr. Reddy
15.11.1 Dr. Reddy Basic Information
15.11.2 Dr. Reddy Repurposed Drugs Product Overview
15.11.3 Dr. Reddy Repurposed Drugs Product Market Performance
15.11.4 Dr. Reddy Business Overview
15.11.5 Dr. Reddy Recent Developments
15.12 R-Pharma
15.12.1 R-Pharma Basic Information
15.12.2 R-Pharma Repurposed Drugs Product Overview
15.12.3 R-Pharma Repurposed Drugs Product Market Performance
15.12.4 R-Pharma Business Overview
15.12.5 R-Pharma Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Repurposed Drugs Market Size by Type (M USD)
Table 4. Global Repurposed Drugs Market Size by Application (M USD)
Table 5. Repurposed Drugs Market Size Comparison by Region (M USD)
Table 6. Global Repurposed Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Repurposed Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Repurposed Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Repurposed Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2024)
Table 11. Global Market Repurposed Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Repurposed Drugs Manufacturing Sites and Area Served
Table 13. Manufacturers Repurposed Drugs Product Type
Table 14. Global Repurposed Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Repurposed Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Repurposed Drugs Market Size Comparison by Region (M USD)
Table 26. Global Repurposed Drugs Market Size by Region (2020-2033) & (M USD)
Table 27. Global Repurposed Drugs Market Size Market Share by Region (2020-2033)
Table 28. Global Repurposed Drugs Sales by Region (2020-2033) & (K MT)
Table 29. Global Repurposed Drugs Sales Market Share by Region (2020-2033)
Table 30. North America Repurposed Drugs Market Size by Country (2020-2033) & (M USD)
Table 31. North America Repurposed Drugs Sales by Country (2020-2033) & (K MT)
Table 32. North America Repurposed Drugs Sales by Type (K MT)
Table 33. North America Repurposed Drugs Market Size by Type (M USD)
Table 34. North America Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 35. North America Repurposed Drugs Market Size (M USD) by Type (2020-2033)
Table 36. North America Repurposed Drugs Sales by Application (K MT)
Table 37. North America Repurposed Drugs Market Size by Application (M USD)
Table 38. North America Repurposed Drugs Sales (K MT) by Application (2020-2033)
Table 39. North America Repurposed Drugs Market Size (M USD) by Application (2020-2033)
Table 40. Europe Repurposed Drugs Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Repurposed Drugs Sales by Country (2020-2033) & (K MT)
Table 42. Europe Repurposed Drugs Sales by Type (K MT)
Table 43. Europe Repurposed Drugs Market Size by Type (M USD)
Table 44. Europe Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 45. Europe Repurposed Drugs Market Size (M USD) by Type (2020-2033)
Table 46. Europe Repurposed Drugs Sales by Application (K MT)
Table 47. Europe Repurposed Drugs Market Size by Application (M USD)
Table 48. Europe Repurposed Drugs Sales (K MT) by Application (2020-2033)
Table 49. Europe Repurposed Drugs Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Repurposed Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Repurposed Drugs Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Repurposed Drugs Sales by Type (K MT)
Table 53. Asia-Pacific Repurposed Drugs Market Size by Type (M USD)
Table 54. Asia-Pacific Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Repurposed Drugs Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Repurposed Drugs Sales by Application (K MT)
Table 57. Asia-Pacific Repurposed Drugs Market Size by Application (M USD)
Table 58. Asia-Pacific Repurposed Drugs Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Repurposed Drugs Market Size (M USD) by Application (2020-2025)
Table 60. South America Repurposed Drugs Market Size by Country (2020-2033) & (M USD)
Table 61. South America Repurposed Drugs Sales by Country (2020-2033) & (K MT)
Table 62. South America Repurposed Drugs Sales by Type (K MT)
Table 63. South America Repurposed Drugs Market Size by Type (M USD)
Table 64. South America Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 65. South America Repurposed Drugs Market Size (M USD) by Type (2020-2033)
Table 66. South America Repurposed Drugs Sales by Application (K MT)
Table 67. South America Repurposed Drugs Market Size by Application (M USD)
Table 68. South America Repurposed Drugs Sales (K MT) by Application (2020-2033)
Table 69. South America Repurposed Drugs Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Repurposed Drugs Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Repurposed Drugs Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Repurposed Drugs Sales by Type (K MT)
Table 73. Middle East and Africa Repurposed Drugs Market Size by Type (M USD)
Table 74. Middle East and Africa Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Repurposed Drugs Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Repurposed Drugs Sales by Application (K MT)
Table 77. Middle East and Africa Repurposed Drugs Market Size by Application (M USD)
Table 78. Middle East and Africa Repurposed Drugs Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Repurposed Drugs Market Size (M USD) by Application (2020-2033)
Table 80. Global Repurposed Drugs Production (K MT) by Region(2020-2025)
Table 81. Global Repurposed Drugs Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Repurposed Drugs Revenue Market Share by Region (2020-2025)
Table 83. Global Repurposed Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Repurposed Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Repurposed Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Repurposed Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Repurposed Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Repurposed Drugs Sales by Type (K MT)
Table 89. Global Repurposed Drugs Market Size by Type (M USD)
Table 90. Global Repurposed Drugs Sales (K MT) by Type (2020-2033)
Table 91. Global Repurposed Drugs Sales Market Share by Type (2020-2033)
Table 92. Global Repurposed Drugs Market Size (M USD) by Type (2020-2033)
Table 93. Global Repurposed Drugs Market Size Share by Type (2020-2033)
Table 94. Global Repurposed Drugs Sales (K MT) by Application
Table 95. Global Repurposed Drugs Market Size by Application(M USD)
Table 96. Global Repurposed Drugs Sales by Application (2020-2033) & (K MT)
Table 97. Global Repurposed Drugs Sales Market Share by Application (2020-2033)
Table 98. Global Repurposed Drugs Market Size by Application (2020-2033) & (M USD)
Table 99. Global Repurposed Drugs Market Share by Application (2020-2033)
Table 100. Global Repurposed Drugs Sales Growth Rate by Application (2020-2033)
Table 101. Teva Basic Information
Table 102. Teva Repurposed Drugs Product Overview
Table 103. Teva Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Teva Business Overview
Table 105. Teva SWOT Analysis
Table 106. Teva Recent Developments
Table 107. Novartis Basic Information
Table 108. Novartis Repurposed Drugs Product Overview
Table 109. Novartis Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Novartis Business Overview
Table 111. Novartis SWOT Analysis
Table 112. Novartis Recent Developments
Table 113. Mylan Basic Information
Table 114. Mylan Repurposed Drugs Product Overview
Table 115. Mylan Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Mylan Business Overview
Table 117. Mylan SWOT Analysis
Table 118. Mylan Recent Developments
Table 119. Johnson and Johnson Basic Information
Table 120. Johnson and Johnson Repurposed Drugs Product Overview
Table 121. Johnson and Johnson Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Johnson and Johnson Business Overview
Table 123. Johnson and Johnson Recent Developments
Table 124. Pfizer Basic Information
Table 125. Pfizer Repurposed Drugs Product Overview
Table 126. Pfizer Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pfizer Business Overview
Table 128. Pfizer Recent Developments
Table 129. Bausch Health Basic Information
Table 130. Bausch Health Repurposed Drugs Product Overview
Table 131. Bausch Health Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Bausch Health Business Overview
Table 133. Bausch Health Recent Developments
Table 134. GSK Basic Information
Table 135. GSK Repurposed Drugs Product Overview
Table 136. GSK Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. GSK Business Overview
Table 138. GSK Recent Developments
Table 139. ChemRar Group Basic Information
Table 140. ChemRar Group Repurposed Drugs Product Overview
Table 141. ChemRar Group Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. ChemRar Group Business Overview
Table 143. ChemRar Group Recent Developments
Table 144. Glenmark Basic Information
Table 145. Glenmark Repurposed Drugs Product Overview
Table 146. Glenmark Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Glenmark Business Overview
Table 148. Glenmark Recent Developments
Table 149. Fujifilm Basic Information
Table 150. Fujifilm Repurposed Drugs Product Overview
Table 151. Fujifilm Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Fujifilm Business Overview
Table 153. Fujifilm Recent Developments
Table 154. Dr. Reddy Basic Information
Table 155. Dr. Reddy Repurposed Drugs Product Overview
Table 156. Dr. Reddy Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Dr. Reddy Business Overview
Table 158. Dr. Reddy Recent Developments
Table 159. R-Pharma Basic Information
Table 160. R-Pharma Repurposed Drugs Product Overview
Table 161. R-Pharma Repurposed Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. R-Pharma Business Overview
Table 163. R-Pharma Recent Developments
List of Figures
Figure 1. Product Picture of Repurposed Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Repurposed Drugs Market Size (M USD), 2024-2033
Figure 5. Global Repurposed Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Repurposed Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Repurposed Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Repurposed Drugs Product Life Cycle
Figure 13. Repurposed Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Repurposed Drugs Revenue Share by Manufacturers in 2024
Figure 15. Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Repurposed Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Repurposed Drugs Revenue in 2024
Figure 18. Industry Chain Map of Repurposed Drugs
Figure 19. Global Repurposed Drugs Market PEST Analysis
Figure 20. Global Repurposed Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Repurposed Drugs Market Size by Region
Figure 27. Global Repurposed Drugs Market Size Market Share by Region (2020-2033)
Figure 28. Global Repurposed Drugs Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Repurposed Drugs Market Size (M USD) by Country
Figure 33. USA Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Repurposed Drugs Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Repurposed Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Repurposed Drugs Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Repurposed Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Repurposed Drugs Market Size (M USD)by Type
Figure 40. North America Repurposed Drugs Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Repurposed Drugs Market Size (M USD) by Country
Figure 45. Germany Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Repurposed Drugs Market Size (M USD) by Type
Figure 56. Europe Repurposed Drugs Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Repurposed Drugs Market Size (M USD) by Country
Figure 61. China Repurposed Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Repurposed Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Repurposed Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Repurposed Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Repurposed Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Repurposed Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Repurposed Drugs Market Size (M USD) by Type
Figure 72. Asia-Pacific Repurposed Drugs Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Repurposed Drugs Market Size (M USD) by Country
Figure 77. Brazil Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Repurposed Drugs Market Size (M USD) by Type
Figure 84. South America Repurposed Drugs Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Repurposed Drugs Market Size (M USD) by Country
Figure 89. Saudi Arabia Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Repurposed Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Repurposed Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Repurposed Drugs Market Size (M USD) by Type
Figure 100. Middle East and Africa Repurposed Drugs Market Size (M USD) by Application
Figure 101. Global Repurposed Drugs Production Market Share by Region (2020-2025)
Figure 102. North America Repurposed Drugs Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Repurposed Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Repurposed Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. China Repurposed Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Repurposed Drugs Market Size by Type (M USD)
Figure 108. Sales Market Share of Repurposed Drugs by Type (2020-2033)
Figure 109. Sales Market Share of Repurposed Drugs by Type in 2024
Figure 110. Market Size Share of Repurposed Drugs by Type (2020-2033)
Figure 111. Market Size Share of Repurposed Drugs by Type in 2024
Figure 112. Global Repurposed Drugs Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Repurposed Drugs Market Size by Application(M USD)
Figure 115. Global Repurposed Drugs Market Share by Application
Figure 116. Global Repurposed Drugs Sales Market Share by Application (2020-2033)
Figure 117. Global Repurposed Drugs Sales Market Share by Application in 2024
Figure 118. Global Repurposed Drugs Market Share by Application (2020-2033)
Figure 119. Global Repurposed Drugs Market Share by Application in 2024
Figure 120. Global Repurposed Drugs Sales Growth Rate by Application (2020-2033)